halofantrine has been researched along with nandrolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Charman, WN; Edwards, GA; Faassen, WA; Nguyen, G; Porter, CJ; White, KL | 1 |
2 other study(ies) available for halofantrine and nandrolone
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
Topics: Administration, Oral; Animals; Antimalarials; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dietary Fats; Dogs; Enterocytes; Estrenes; Fasting; Injections, Intravenous; Lymph; Lymphatic System; Male; Nandrolone; Phenanthrenes; Rats; Rats, Sprague-Dawley; Solubility; Spectrophotometry, Ultraviolet; Triglycerides | 2009 |